MA 02.10 Phase I Study of ABBV-399 (Telisotuzumab Vedotin) as Monotherapy and in Combination with Erlotinib in NSCLC

Authors :: Karen Kelly
J. Beaulieu
Jonathan H. Goldman
Daniel E. H. Afar
Louie Naumovski
John H. Strickler
Eric Angevin
Huibin Yue
Monica Motwani
D.R. Camidge
M. Barve
Rebecca S. Heist
Daniel Morgensztern
Source :: Journal of Thoracic Oncology. 12:S1805-S1806
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Phase i study
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Erlotinib
business
medicine.drug

Tools